Harbour Investments’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76
Closed -$75 4740
2025
Q4
$75 Hold
76
﹤0.01% 3757
2025
Q3
$116 Hold
76
﹤0.01% 3630
2025
Q2
$73 Hold
76
﹤0.01% 3536
2025
Q1
$95 Sell
76
-1
-1% -$4 ﹤0.01% 3479
2024
Q4
$679 Hold
77
﹤0.01% 3239
2024
Q3
$902 Hold
77
﹤0.01% 3110
2024
Q2
$1.81K Buy
+77
New +$1.46K ﹤0.01% 2840

Other funds holding MBIO

Harbour Investments's MBIO Position: Q1 2026 in Review

Harbour Investments sold out of Mustang Bio (MBIO) in Q1 2026, closing a stake of 76 shares — an estimated $75 sold.

Harbour Investments first reported a position in MBIO in Q2 2024 and held it in 7 quarters. The position peaked at $1.81K in Q2 2024. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • Harbour Investments reported no remaining Mustang Bio position as of Q1 2026 after selling out during the quarter.
  • Harbour Investments sold 76 Mustang Bio shares in Q1 2026, an estimated $75.
  • Harbour Investments first reported a position in Mustang Bio in Q2 2024 and held it in 7 quarters.
  • Harbour Investments's Mustang Bio position peaked at $1.81K in Q2 2024.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.